{"id":"https://openalex.org/W1990665357","doi":"https://doi.org/10.2133/dmpk.dmpk-10-rg-108","title":"Nasal Delivery of P-gp Substrates to the Brain through the Nose\u2013Brain Pathway","display_name":"Nasal Delivery of P-gp Substrates to the Brain through the Nose\u2013Brain Pathway","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W1990665357","doi":"https://doi.org/10.2133/dmpk.dmpk-10-rg-108","mag":"1990665357","pmid":"https://pubmed.ncbi.nlm.nih.gov/21317541"},"language":"en","primary_location":{"id":"doi:10.2133/dmpk.dmpk-10-rg-108","doi":"https://doi.org/10.2133/dmpk.dmpk-10-rg-108","is_oa":false,"landing_page_url":"https://doi.org/10.2133/dmpk.dmpk-10-rg-108","pdf_url":null,"source":{"id":"https://openalex.org/S185835163","display_name":"Drug Metabolism and Pharmacokinetics","issn_l":"1347-4367","issn":["1347-4367","1880-0920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Pharmacokinetics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102969467","display_name":"Tomotaka Shingaki","orcid":"https://orcid.org/0000-0002-7046-2097","observed_orcids":["https://orcid.org/0000-0002-7046-2097"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Tomotaka Shingaki","raw_affiliation_strings":["ADME Research Inc., Minoh, Japan. t.shingaki@adme.jp","ADME Research Inc., Minoh, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ADME Research Inc., Minoh, Japan. t.shingaki@adme.jp","institution_ids":[]},{"raw_affiliation_string":"ADME Research Inc., Minoh, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041273107","display_name":"Ismael J. Hidalgo","orcid":"https://orcid.org/0000-0001-6973-1627","observed_orcids":["https://orcid.org/0000-0001-6973-1627"]},"institutions":[{"id":"https://openalex.org/I4210136999","display_name":"Absorption Systems (United States)","ror":"https://ror.org/03br5ck68","country_code":"US","type":"company","lineage":["https://openalex.org/I4210136999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ismael J. Hidalgo","raw_affiliation_strings":["Absorption Systems, Exton, USA","Absorption Systems"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Absorption Systems, Exton, USA","institution_ids":["https://openalex.org/I4210136999"]},{"raw_affiliation_string":"Absorption Systems","institution_ids":["https://openalex.org/I4210136999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009560589","display_name":"Tomoyuki Furubayashi","orcid":"https://orcid.org/0000-0002-4397-4353","observed_orcids":["https://orcid.org/0000-0002-4397-4353"]},"institutions":[{"id":"https://openalex.org/I129844524","display_name":"Shujitsu University","ror":"https://ror.org/03mezqr97","country_code":"JP","type":"education","lineage":["https://openalex.org/I129844524"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoyuki Furubayashi","raw_affiliation_strings":["School of Pharmacy, Shujitsu University, Okayama, Japan","School of Pharmacy, Shujitsu University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Shujitsu University, Okayama, Japan","institution_ids":["https://openalex.org/I129844524"]},{"raw_affiliation_string":"School of Pharmacy, Shujitsu University","institution_ids":["https://openalex.org/I129844524"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025085721","display_name":"Toshiyasu Sakane","orcid":"https://orcid.org/0000-0002-6504-0623","observed_orcids":["https://orcid.org/0000-0002-6504-0623"]},"institutions":[{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshiyasu Sakane","raw_affiliation_strings":["Kyoto Pharmaceutical University, Yamashina, Japan","Kyoto Pharmaceutical University;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kyoto Pharmaceutical University, Yamashina, Japan","institution_ids":["https://openalex.org/I25998863"]},{"raw_affiliation_string":"Kyoto Pharmaceutical University;","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069866009","display_name":"Hidemasa Katsumi","orcid":"https://orcid.org/0000-0001-5078-7276","observed_orcids":["https://orcid.org/0000-0001-5078-7276"]},"institutions":[{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hidemasa Katsumi","raw_affiliation_strings":["Kyoto Pharmaceutical University, Yamashina, Japan","Kyoto Pharmaceutical University;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kyoto Pharmaceutical University, Yamashina, Japan","institution_ids":["https://openalex.org/I25998863"]},{"raw_affiliation_string":"Kyoto Pharmaceutical University;","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060619493","display_name":"Akira Yamamoto","orcid":"https://orcid.org/0000-0002-6250-5472","observed_orcids":["https://orcid.org/0000-0002-6250-5472"]},"institutions":[{"id":"https://openalex.org/I25998863","display_name":"Kyoto Pharmaceutical University","ror":"https://ror.org/01ytgve10","country_code":"JP","type":"education","lineage":["https://openalex.org/I25998863"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akira Yamamoto","raw_affiliation_strings":["Kyoto Pharmaceutical University, Yamashina, Japan","Kyoto Pharmaceutical University;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kyoto Pharmaceutical University, Yamashina, Japan","institution_ids":["https://openalex.org/I25998863"]},{"raw_affiliation_string":"Kyoto Pharmaceutical University;","institution_ids":["https://openalex.org/I25998863"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029718117","display_name":"Shinji Yamashita","orcid":"https://orcid.org/0000-0002-6443-9958","observed_orcids":["https://orcid.org/0000-0002-6443-9958"]},"institutions":[{"id":"https://openalex.org/I102826571","display_name":"Setsunan University","ror":"https://ror.org/0418a3v02","country_code":"JP","type":"education","lineage":["https://openalex.org/I102826571"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinji Yamashita","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Japan","Faculty of Pharmaceutical Sciences, Setsunan University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Setsunan University, Hirakata, Japan","institution_ids":["https://openalex.org/I102826571"]},{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Setsunan University","institution_ids":["https://openalex.org/I102826571"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5102969467"],"corresponding_institution_ids":[],"apc_list":{"value":3580,"currency":"USD","value_usd":3580},"apc_paid":null,"fwci":0.6368,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.61568047,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"26","issue":"3","first_page":"248","last_page":"255"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.6089000105857849,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.6089000105857849,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.29660001397132874,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.03480000048875809,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/intranasal-drug-delivery","display_name":"intranasal drug delivery","score":0.9629999995231628},{"id":"https://openalex.org/keywords/p-glycoprotein-substrate","display_name":"P-glycoprotein substrate","score":0.968999981880188},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.7990000247955322},{"id":"https://openalex.org/keywords/talinolol","display_name":"talinolol","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/drug-delivery-to-the-brain","display_name":"brain drug delivery","score":0.6959999799728394},{"id":"https://openalex.org/keywords/cerebrospinal-fluid","display_name":"cerebrospinal fluid","score":0.9010000228881836},{"id":"https://openalex.org/keywords/p-glycoprotein-inhibitors","display_name":"P-glycoprotein inhibitors","score":0.6830000281333923}],"concepts":[{"id":"https://openalex.org/C2777022698","wikidata":"https://www.wikidata.org/wiki/Q410291","display_name":"Verapamil","level":3,"score":0.8655625581741333},{"id":"https://openalex.org/C85663871","wikidata":"https://www.wikidata.org/wiki/Q6966562","display_name":"Nasal administration","level":2,"score":0.7369276881217957},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6838288903236389},{"id":"https://openalex.org/C146957229","wikidata":"https://www.wikidata.org/wiki/Q1266915","display_name":"Perfusion","level":2,"score":0.6042360663414001},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5833572745323181},{"id":"https://openalex.org/C2778801703","wikidata":"https://www.wikidata.org/wiki/Q156104","display_name":"Nasal cavity","level":2,"score":0.5540168881416321},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.4546918272972107},{"id":"https://openalex.org/C2778311950","wikidata":"https://www.wikidata.org/wiki/Q7363","display_name":"Nose","level":2,"score":0.4509059488773346},{"id":"https://openalex.org/C2779651940","wikidata":"https://www.wikidata.org/wiki/Q54196","display_name":"Cerebrospinal fluid","level":2,"score":0.45065543055534363},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.4141947627067566},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.36935728788375854},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19333425164222717},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1918272078037262},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.10312941670417786},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.07317090034484863},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000281","descriptor_name":"Administration, Intranasal","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010477","descriptor_name":"Perfusion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011412","descriptor_name":"Propanolamines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D011412","descriptor_name":"Propanolamines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011412","descriptor_name":"Propanolamines","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D011412","descriptor_name":"Propanolamines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011412","descriptor_name":"Propanolamines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000134","qualifier_name":"cerebrospinal fluid","is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018435","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018435","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2133/dmpk.dmpk-10-rg-108","doi":"https://doi.org/10.2133/dmpk.dmpk-10-rg-108","is_oa":false,"landing_page_url":"https://doi.org/10.2133/dmpk.dmpk-10-rg-108","pdf_url":null,"source":{"id":"https://openalex.org/S185835163","display_name":"Drug Metabolism and Pharmacokinetics","issn_l":"1347-4367","issn":["1347-4367","1880-0920"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism and Pharmacokinetics","raw_type":"journal-article"},{"id":"pmid:21317541","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21317541","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug metabolism and pharmacokinetics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1495673478","https://openalex.org/W1527910050","https://openalex.org/W1529844523","https://openalex.org/W1925440308","https://openalex.org/W1965256752","https://openalex.org/W1976490782","https://openalex.org/W1979205093","https://openalex.org/W1979542218","https://openalex.org/W1984859656","https://openalex.org/W2004281677","https://openalex.org/W2004394555","https://openalex.org/W2010859559","https://openalex.org/W2016587975","https://openalex.org/W2016661048","https://openalex.org/W2023731023","https://openalex.org/W2029977872","https://openalex.org/W2034370816","https://openalex.org/W2038622171","https://openalex.org/W2041049648","https://openalex.org/W2050946834","https://openalex.org/W2077756131","https://openalex.org/W2082799656","https://openalex.org/W2083337622","https://openalex.org/W2083348828","https://openalex.org/W2083673453","https://openalex.org/W2085950561","https://openalex.org/W2086190854","https://openalex.org/W2087530953","https://openalex.org/W2113945122","https://openalex.org/W2117024164","https://openalex.org/W2117674127","https://openalex.org/W2123541107","https://openalex.org/W2124510197","https://openalex.org/W2133475198","https://openalex.org/W2136307753","https://openalex.org/W2146939143","https://openalex.org/W2156600347","https://openalex.org/W2169889836","https://openalex.org/W2170227869","https://openalex.org/W2171098193","https://openalex.org/W2474479430"],"related_works":["https://openalex.org/W2163771644","https://openalex.org/W33316805","https://openalex.org/W2016661048","https://openalex.org/W1998989929","https://openalex.org/W2926167513","https://openalex.org/W3018683504","https://openalex.org/W2047600220","https://openalex.org/W2033980704","https://openalex.org/W2591061287","https://openalex.org/W7020063690"],"abstract_inverted_index":{"The":[0,55,156,170],"objective":[1],"of":[2,13,24,57,103,114,123,142,151,172,178,188,202,209],"this":[3],"study":[4],"was":[5,65,89,132,165,183],"to":[6,17,180],"evaluate":[7],"in":[8,59,73,128,147],"rats":[9,95],"the":[10,14,60,74,77,85,121,129,136,148,162,181,199,207],"potential":[11,157],"utility":[12],"nasal":[15,50,63,92,137,173,192],"route":[16,164],"enhance":[18],"central":[19],"nervous":[20],"system":[21],"(CNS)":[22],"delivery":[23,160,174,177,201],"drugs":[25],"recognized":[26],"by":[27,144],"P-glycoprotein":[28],"(P-gp).":[29],"Well-known":[30],"P-gp":[31,145,168,204,210],"substrates":[32,205],"verapamil":[33,58,104],"and":[34,42,49,76],"talinolol":[35,72,115,124,127,179],"were":[36,83,96,109,116],"perfused":[37],"nasally":[38],"or":[39],"infused":[40],"intravenously,":[41],"when":[43],"plasma":[44],"concentrations":[45,102],"following":[46],"intravenous":[47,69],"infusion":[48,82],"perfusion":[51,64],"showed":[52],"similar":[53],"profiles.":[54],"concentration":[56],"brain":[61,75,101,130,182,200],"after":[62,68,80,91,105],"twice":[66],"that":[67,187,191],"infusion.":[70],"Although":[71],"cerebrospinal":[78],"fluid":[79],"i.v.":[81,176],"below":[84],"detection":[86],"limit,":[87],"it":[88],"detected":[90],"perfusion.":[93],"When":[94],"treated":[97],"with":[98],"cyclosporin":[99],"A,":[100],"both":[106],"administration":[107,193],"modes":[108],"increased":[110],"significantly,":[111],"while":[112],"those":[113],"not":[117],"significantly":[118],"changed.":[119],"Since":[120],"permeability":[122],"is":[125,194],"low,":[126],"which":[131],"transported":[133],"directly":[134],"from":[135],"cavity":[138],"has":[139],"little":[140],"chance":[141],"transport":[143],"localized":[146],"apical":[149],"membrane":[150],"cerebral":[152],"microvessel":[153],"endothelial":[154],"cells.":[155],"for":[158,167,198],"drug":[159],"utilizing":[161],"nose-CNS":[163],"confirmed":[166],"substrates.":[169],"advantage":[171],"over":[175],"more":[184,195],"significant":[185],"than":[186,206],"verapamil,":[189],"suggesting":[190],"useful":[196],"strategy":[197],"low-permeability":[203],"use":[208],"inhibitors.":[211]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}